Kelsey-Seybold Clinic / Memorial Villages Lab

CLIA Laboratory Citation Details

3
Total Citations
10
Total Deficiencyies
4
Unique D-Tags
CMS Certification Number 45D2264730
Address 9110 Katy Freeway, Houston, TX, 77055
City Houston
State TX
Zip Code77055
Phone(713) 442-6900

Citation History (3 surveys)

Survey - June 17, 2026

Survey Type: Complaint

Survey Event ID: 04T911

Deficiency Tags: D0000 D5801 D5311

Summary:

Summary Statement of Deficiencies D0000 The Kelsey-Seybold Clinics/Memorial Villages laboratory was surveyed in response to complaint TX00562643 for compliance with CLIA CMS 42 CFR regulations. The complaint TX00562643 was substantiated. Standard level deficiencies were cited. D5311 SPECIMEN SUBMISSION, HANDLING, AND REFERRAL CFR(s): 493.1242(a) (a) The laboratory must establish and follow written policies and procedures for each of the following, if applicable: (a)(1) Patient preparation. (a)(2) Specimen collection. (a)(3) Specimen labeling, including patient name or unique patient identifier and, when appropriate, specimen source. (a)(4) Specimen storage and preservation. (a)(5) Conditions for specimen transportation. (a)(6) Specimen processing. (a)(7) Specimen acceptability and rejection. (a)(8) Specimen referral. This STANDARD is not met as evidenced by: Based on a review of the laboratory's policies, patient test records, and staff interview, the laboratory failed to ensure one of three patient's urine specimen was collected according to the laboratory's procedure, ensuring the collection time was accurate, for testing in November 2025. Findings include: 1. A review of the laboratory's policy titled 'Urine Specimen Processing and Management' revealed the following: "Urine In- Office Collection for Satellite Sites - If a patient can void at site: a) Print a visit label b) Verify patient name with patient c) Place label on the cup. - Give patient clear instructions on urine collection: a) Inform patient urine collection instructions are also posted on the restroom wall. b) Instruct the patient to place their urine collection in the pass-through window. - The PST (Patient Services Technician) should retrieve the collected urine from the pass-through window and perform: a) Collect the urine in EPIC. b) Print the label. c) Deliver the urine to the processing area. - PSTs and Processors are responsible for routinely checking the urine pass-through window throughout the day. a) The pass-through window should be checked at a minimum every 10-15 minutes to prevent buildup of urine cups." 2. A review of patient test Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- record revealed the time the following patient checked in and checked out of the Laboratory Services Department for routine urinalysis testing: - Patient ID: 92010115 Date: 11/6/25 Check in time: 08:01 a.m. Check out time: 08:07 a.m. 3. Further review of the patient test record revealed the laboratory documented the following collection time for the urine specimen: - Patient ID: 92010115 Documented urine collection time: 09:55 a.m. Elapsed time from check out to documented collection time: 1 hour 48 minutes 4. In an interview on 6/17/26 at 11:40 a.m. in the office, after review of the records, the compliance manager confirmed that if the samples are ordered as routine, the samples are batched and tested when time allows. For this patient specimen, the documented collection time was actually the time the urine was tested and resulted. D5801 TEST REPORT CFR(s): 493.1291(a) (a) The laboratory must have an adequate manual or electronic system(s) in place to ensure test results and other patient-specific data are accurately and reliably sent from the point of data entry (whether interfaced or entered manually) to final report destination, in a timely manner. This includes the following: (a)(1) Results reported from calculated data. (a)(2) Results and patient-specific data electronically reported to network or interfaced systems. (a)(3) Manually transcribed or electronically transmitted results and patient-specific information reported directly or upon receipt from outside referral laboratories, satellite or point-of-care testing locations. This STANDARD is not met as evidenced by: Based on a review of test requisitions, a review of patient final reports, and staff interview, the laboratory failed to ensure the final test report reflected the correct collection time for one of ten patient reports reviewed from March 2026. Findings include: 1. A review of the test requisition for Patient ID: 89634638 revealed the following tests were ordered on 3/24/26: a) Cortisol - AM, Total Order comments: 8 am lab draw to be collected BEFORE Cosyntropin administration b) Cortisol Order comments: 8:30 lab draw to be collected 30 minutes AFTER Cosyntropin administration c) Cortisol- AM, Total Order Comments: hour draw d) Cortisol 2. A review of the patient's final report revealed the following collection times for the Cortisol tests: a) Cortisol 8:00 a.m. b) Cortisol 8:46 a.m. c) Cortisol 12:19 p.m. 3. Further review of the patient's final report revealed, the 'Cortisol- AM, Total order comments: hour draw', was collected at 3/24/26 9:46 a.m. but then canceled as a duplicate test. The results for the hour draw were then resulted under the 'Cortisol' test order with a collection time of 12:19 p.m. 4. In an interview on 6/17/26 at 12:33 p.m. in the office, after review of the records, the compliance manager confirmed the hour draw should have been ordered as a 'Cortisol' test, not a 'Cortisol- AM, Total' test. When the laboratory identified the error, the order was canceled, however, the collection time was not entered correctly for the hour draw. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - November 6, 2024

Survey Type: Standard

Survey Event ID: H37I11

Deficiency Tags: D0000 D5311 D0000 D5311

Summary:

Summary Statement of Deficiencies D0000 The laboratory was surveyed and found to be in compliance with the Conditions of the CLIA regulations found at 42 CFR 493.1 through 493.1780, and recertification is recommended. Standard level deficiencies were cited. D5311 SPECIMEN SUBMISSION, HANDLING, AND REFERRAL CFR(s): 493.1242(a) The laboratory must establish and follow written policies and procedures for each of the following, if applicable: (1) Patient preparation. (2) Specimen collection. (3) Specimen labeling, including patient name or unique patient identifier and, when appropriate, specimen source. (4) Specimen storage and preservation. (5) Conditions for specimen transportation. (6) Specimen processing. (7) Specimen acceptability and rejection. (8) Specimen referral. This STANDARD is not met as evidenced by: Based on a review of the laboratory's policies, surveyor observation, the laboratory's records, and staff interview, the laboratory failed to follow their policy for centrifuging patient samples for 42 of 42 urine microscopic examinations performed from October 1, 2024 to November 6, 2024. Findings include: 1. A review of the laboratory's policy titled 'Urinalysis Microscopic Examination' revealed the following: "Centrifuge for 5 minutes at 1500 rpm/450 rcf." 2. Surveyor observation of the laboratory on 11/6/24 at 12:40 p.m. revealed the laboratory staff used the following centrifuge for urine microscopic examinations: -Medline Model 642E Serial number (SN): 220913IG483 3. A review of the laboratory's Service Request Detail records for the Medline centrifuge (SN: 220913IG483) revealed the Revolutions per Minute (RPMs) and timing were tested on 8/29/24 with the following results: 3173 rpm 10 minutes 4. A review of the laboratory's records revealed the laboratory had performed 42 urine microscopic examinations using the Medline centrifuge (SN: 220913IG483) Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- from October 1, 2024 to November 6, 2024. 5. In an interview on 11/6/24 at 12:50 p. m. in the conference room, after review of the records, the laboratory compliance manager confirmed the above findings. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - March 29, 2023

Survey Type: Standard

Survey Event ID: ES8O11

Deficiency Tags: D0000 D5209 D5209

Summary:

Summary Statement of Deficiencies D0000 The laboratory was found out of compliance with applicable CLIA regulations (42 CFR Part 493, Requirements for Laboratories). The facility representative was given an opportunity to provide evidence of compliance with the noted deficiencies, and no such evidence was provided prior to survey exit. Noted deficiencies and plans of correction were discussed with the laboratory representative(s) at the exit conference. The facility was found in compliance with applicable CLIA conditions, and recertification is recommended. Note: The CMS-2567 (Statement of Deficiencies) is an official, legal document. All information must remain unchanged except for entering the

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access